Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
80.36 USD | +9.75% | +12.52% | +12.52% |
May. 08 | Sector Update: Health Care Stocks Softer Late Afternoon | MT |
May. 08 | Ligand Pharmaceuticals Shares Rise After Q1 Adjusted Earnings, Revenue Beat Views | MT |
Financials (USD)
Sales 2024 * | 138M | Sales 2025 * | 158M | Capitalization | 1.44B |
---|---|---|---|---|---|
Net income 2024 * | 39M | Net income 2025 * | 51M | EV / Sales 2024 * | 10.5 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 9.15 x |
P/E ratio 2024 * |
36.7
x | P/E ratio 2025 * |
28.1
x | Employees | 58 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.56% |
Latest transcript on Ligand Pharmaceuticals Incorporated
1 day | +9.75% | ||
1 week | +12.52% | ||
Current month | +14.98% | ||
1 month | +0.95% | ||
3 months | +6.56% | ||
6 months | +53.86% | ||
Current year | +12.52% |
Managers | Title | Age | Since |
---|---|---|---|
Todd Davis
CEO | Chief Executive Officer | 63 | 07-02-28 |
Octavio Espinoza
DFI | Director of Finance/CFO | 53 | 22-10-31 |
President | 49 | 15-08-05 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Kozarich
CHM | Chairman | 74 | 03-02-28 |
John LaMattina
BRD | Director/Board Member | 74 | 11-01-31 |
Stephen Sabba
BRD | Director/Board Member | 64 | 08-08-03 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.24% | 0 M€ | -3.26% | - | |
0.14% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 80.36 | +9.75% | 286,949 |
24-05-07 | 73.22 | +0.54% | 162,711 |
24-05-06 | 72.83 | -1.45% | 114,789 |
24-05-03 | 73.9 | +2.18% | 141,782 |
24-05-02 | 72.32 | +1.26% | 146,548 |
Delayed Quote Nasdaq, May 08, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.52% | 1.31B | |
+32.95% | 700B | |
+26.51% | 569B | |
-4.97% | 358B | |
+18.83% | 330B | |
+3.54% | 287B | |
+15.70% | 236B | |
+6.68% | 202B | |
-9.08% | 197B | |
+6.70% | 161B |
- Stock Market
- Equities
- LGND Stock